NKG2E comprises an immunogenic peptide, derived from an alu-retrotransposon: An attractive novel target for immunotherapeutic approaches

SI Papamichos

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	ANNALS OF ONCOLOGY
Volume	30
Publication status	Published - 2019
Event	Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) - Geneva, SWITZERLAND Duration: 11 Dec 2019 → 14 Dec 2019

Cite this

@article{3cedb92415ee4df8b0b7b056e678a806,

title = "NKG2E comprises an immunogenic peptide, derived from an alu-retrotransposon: An attractive novel target for immunotherapeutic approaches",

author = "SI Papamichos",

year = "2019",

language = "English",

volume = "30",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

note = "Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 11-12-2019 Through 14-12-2019",

}

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - NKG2E comprises an immunogenic peptide, derived from an alu-retrotransposon: An attractive novel target for immunotherapeutic approaches

AU - Papamichos, SI

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0923-7534

VL - 30

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

T2 - Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)

Y2 - 11 December 2019 through 14 December 2019

ER -